429 related articles for article (PubMed ID: 22473649)
1. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors.
Kaatz S; Kouides PA; Garcia DA; Spyropolous AC; Crowther M; Douketis JD; Chan AK; James A; Moll S; Ortel TL; Van Cott EM; Ansell J
Am J Hematol; 2012 May; 87 Suppl 1():S141-5. PubMed ID: 22473649
[TBL] [Abstract][Full Text] [Related]
2. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
[TBL] [Abstract][Full Text] [Related]
3. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
Tummala R; Kavtaradze A; Gupta A; Ghosh RK
Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulants and status of antidotes for the reversal of bleeding risk.
Ebright J; Mousa SA
Clin Appl Thromb Hemost; 2015 Mar; 21(2):105-14. PubMed ID: 25115762
[TBL] [Abstract][Full Text] [Related]
5. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Eerenberg ES; Kamphuisen PW; Sijpkens MK; Meijers JC; Buller HR; Levi M
Circulation; 2011 Oct; 124(14):1573-9. PubMed ID: 21900088
[TBL] [Abstract][Full Text] [Related]
6. Current state of knowledge on oral anticoagulant reversal using procoagulant factors.
Nitzki-George D; Wozniak I; Caprini JA
Ann Pharmacother; 2013 Jun; 47(6):841-55. PubMed ID: 23695644
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant management in the cardiovascular setting.
Verheugt FW
Fundam Clin Pharmacol; 2012 Feb; 26(1):11-5. PubMed ID: 21831129
[TBL] [Abstract][Full Text] [Related]
8. Reversal of direct oral anticoagulants: a practical approach.
Shih AW; Crowther MA
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):612-619. PubMed ID: 27913536
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?
van Montfoort ML; Meijers JC
Thromb Haemost; 2013 Aug; 110(2):223-32. PubMed ID: 23739841
[TBL] [Abstract][Full Text] [Related]
10. Monitoring and reversal strategies for new oral anticoagulants.
Vanden Daelen S; Peetermans M; Vanassche T; Verhamme P; Vandermeulen E
Expert Rev Cardiovasc Ther; 2015 Jan; 13(1):95-103. PubMed ID: 25431993
[TBL] [Abstract][Full Text] [Related]
11. Developing a management plan for oral anticoagulant reversal.
Dager WE
Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S21-31. PubMed ID: 23640529
[TBL] [Abstract][Full Text] [Related]
12. [Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal)].
Vicente V; Martín A; Lecumberri R; Coll-Vinent B; Suero C; González-Porras JR; Marco P; Mateo J; Roldán V; Soulard S; Crespo C; Camats M;
Emergencias; 2017 Feb; 29(1):18-26. PubMed ID: 28825264
[TBL] [Abstract][Full Text] [Related]
13. Antidotes for novel oral anticoagulants: current status and future potential.
Crowther M; Crowther MA
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1736-45. PubMed ID: 26088576
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with inhibitors of new oral direct anticoagulants in patients with severe bleedings or urgent surgical procedures. The new dabigatran antidote: the place of idarucizumab in clinical practice].
Boda Z
Orv Hetil; 2016 Mar; 157(12):443-50. PubMed ID: 26971644
[TBL] [Abstract][Full Text] [Related]
15. Potential antidotes for reversal of old and new oral anticoagulants.
Suryanarayan D; Schulman S
Thromb Res; 2014 May; 133 Suppl 2():S158-66. PubMed ID: 24862137
[TBL] [Abstract][Full Text] [Related]
16. [Direct oral anticoagulant associated bleeding].
Godier A; Martin AC; Rosencher N; Susen S
J Mal Vasc; 2016 Jul; 41(4):272-8. PubMed ID: 27297642
[TBL] [Abstract][Full Text] [Related]
17. Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants.
Dhakal P; Rayamajhi S; Verma V; Gundabolu K; Bhatt VR
Clin Appl Thromb Hemost; 2017 Jul; 23(5):410-415. PubMed ID: 27789605
[TBL] [Abstract][Full Text] [Related]
18. Novel oral anticoagulants. Part II: direct thrombin inhibitors.
Mehta RS
Expert Rev Hematol; 2010 Jun; 3(3):351-61. PubMed ID: 21082985
[TBL] [Abstract][Full Text] [Related]
19. Reversing targeted oral anticoagulants.
Hoffman M; Monroe DM
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):518-23. PubMed ID: 25696904
[TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.
Zikria JC; Ansell J
Curr Opin Hematol; 2009 Sep; 16(5):347-56. PubMed ID: 19550318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
